Surgical outcomes and prognostic factors of oral cancer associated with betel quid chewing and tobacco smoking in Taiwan
- PMID: 20138564
- DOI: 10.1016/j.oraloncology.2010.01.008
Surgical outcomes and prognostic factors of oral cancer associated with betel quid chewing and tobacco smoking in Taiwan
Abstract
Oral squamous cell carcinoma (OSCC) is one of the most common cancers in geographic regions where betel quid (BQ) chewing is prevalent; OSCC is an extremely malignant neoplasm whose prognostic factors are multiple and complex. The purpose of this study was to assess clinicopathological prognostic factors and treatment outcomes in 698 consecutive OSCC patients who had undergone surgery as the primary treatment in an area with a high prevalence of both betel quid chewing and tobacco smoking. The prognostic factors were predicted using Cox's proportional-hazards regression model, and the survival rate was calculated using Kaplan-Meier analysis. The median followup for all patients was 44 months. The 5-year cumulative overall, disease-specific, and locoregional control survival rates were 61%, 62%, and 46%, respectively. Multivariate analysis showed that the lower level of nodal metastasis, advanced stage, tumor thickness >7 mm, and treatment failures were independent risk factors of overall survival. Furthermore, history of alcohol drinking, lower level of nodal metastasis, advanced stage, poor cell differentiation, and treatment failures were independent predictors of poor disease-specific survival. However, we did not find any significant factor that affected locoregional recurrence. Due to the high frequencies of locoregional recurrence and second primary cancer, our findings emphasize that aggressive surgical excision, adjuvant treatments according to clinicopathological prognostic factors and close surveillance are important to the survival of OSCC patients in an area with a high prevalence of betel quid chewing and tobacco smoking.
Copyright 2010 Elsevier Ltd. All rights reserved.
Similar articles
-
Univariate and multivariate analysis of prognostic significance of betel quid chewing in squamous cell carcinoma of buccal mucosa in Taiwan.J Surg Oncol. 2005 Jul 1;91(1):41-7. doi: 10.1002/jso.20276. J Surg Oncol. 2005. PMID: 15999357
-
Quantification of betel quid chewing and cigarette smoking in oral cancer patients.Community Dent Oral Epidemiol. 2009 Dec;37(6):555-61. doi: 10.1111/j.1600-0528.2009.00504.x. Epub 2009 Oct 14. Community Dent Oral Epidemiol. 2009. PMID: 19845714
-
Incidence and Outcomes of Patients With Oral Cavity Squamous Cell Carcinoma and Fourth Primary Tumors: A Long-term Follow-up Study in a Betel Quid Chewing Endemic Area.Medicine (Baltimore). 2016 Mar;95(12):e2950. doi: 10.1097/MD.0000000000002950. Medicine (Baltimore). 2016. PMID: 27015170 Free PMC article.
-
Head and neck cancer in the betel quid chewing area: recent advances in molecular carcinogenesis.Cancer Sci. 2008 Aug;99(8):1507-14. doi: 10.1111/j.1349-7006.2008.00863.x. Cancer Sci. 2008. PMID: 18754860 Free PMC article. Review.
-
Betel quid chewing without tobacco: a meta-analysis of carcinogenic and precarcinogenic effects.Asia Pac J Public Health. 2015 Mar;27(2):NP47-57. doi: 10.1177/1010539513486921. Epub 2013 May 10. Asia Pac J Public Health. 2015. PMID: 23666841 Review.
Cited by
-
Development and validation of machine learning-based risk prediction models of oral squamous cell carcinoma using salivary autoantibody biomarkers.BMC Oral Health. 2022 Nov 24;22(1):534. doi: 10.1186/s12903-022-02607-2. BMC Oral Health. 2022. PMID: 36424594 Free PMC article.
-
Daxx and TCF4 interaction links to oral squamous cell carcinoma growth by promoting cell cycle progression via induction of cyclin D1 expression.Clin Oral Investig. 2016 Apr;20(3):533-40. doi: 10.1007/s00784-015-1536-y. Epub 2015 Jul 24. Clin Oral Investig. 2016. PMID: 26205068 Free PMC article.
-
Molecular Biomarkers Related to Oral Carcinoma: Clinical Trial Outcome Evaluation in a Literature Review.Dis Markers. 2019 Mar 25;2019:8040361. doi: 10.1155/2019/8040361. eCollection 2019. Dis Markers. 2019. PMID: 31019584 Free PMC article.
-
Trends in clinical features and survival of oral cavity cancer: fifty years of experience with 3,362 consecutive cases from a single institution.Cancer Manag Res. 2018 Oct 12;10:4523-4535. doi: 10.2147/CMAR.S171251. eCollection 2018. Cancer Manag Res. 2018. PMID: 30349385 Free PMC article.
-
Expression analysis of SPARC/osteonectin in oral squamous cell carcinoma patients: from saliva to surgical specimen.Biomed Res Int. 2013;2013:736438. doi: 10.1155/2013/736438. Epub 2013 Dec 16. Biomed Res Int. 2013. PMID: 24396828 Free PMC article. Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical